EUVIMEDEUVIMED entdecken
Crossref

Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes

Mengxue He, Aiyang Liu, Jiachen Shi, Yong-Jiang Xu iD, Yuanfa Liu

Cannabis & Cannabinoid Research · 2024

DOI: 10.1089/can.2022.0331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, 2024. Verfasst von Mengxue He und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food,…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cannabidiol, Metabolomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cannabidiol (CBD) has important pharmacological activity, which includes antispasmodic, antioxidant, antithrombotic, and antianxiety properties. CBD has been applied as a health supplement to atherosclerosis. However, CBDs effect on gut microbiota and metabolic phenotype is unclear. Materials and Methods: We constructed a high production of cardiovascular risk factors, such as trimethylamine-N-oxide (TMAO) and phenylacetylglutamine (PAGln), in a mouse model using Clostridium sporogenes colonization. We used 16S ribosomal RNA (rRNA) gene sequencing and ultra-high performance liquid chromatography-quadrupole time-of flight mass spectrometry-based metabolomics to evaluate the effect of CBD on gut microbiota and plasma metabolites.

Results

CBD decreased the levels of creatine kinase (CK), alanine transaminase (ALT), and low-density lipoprotein cholesterol and markedly increased high-density lipoprotein cholesterol. Furthermore, CBD treatment increased the abundance of beneficial bacteria, which include Lachnospiraceae_NK4A136 and Blautia in the gut, but it decreased the levels of TMAO and PAGln in the plasma.

Conclusion

CBD might have beneficial effects for cardiovascular protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCannabidiolMetabolomicsAnimalsMiceMalePhenotypeRNA, Ribosomal, 16SMethylaminesMice, Inbred C57BLMultiomics

Stichwörter der Autor:innen

CBDcardiovascular protectiongut microbiotametabolic phenotype

Substanzen

CannabidioltrimethyloxamineRNA, Ribosomal, 16SMethylamines

Autor:innen und Institutionen

  • State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food, National Engineering Laboratory for Cereal Fermentation Technology, C…

ORCID-Profile: Yong-Jiang Xu

Zitieren

APA

He, M., Liu, A., Shi, J., Xu, Y. J., & Liu, Y. (2024). Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes. Cannabis & Cannabinoid Research. https://doi.org/10.1089/can.2022.0331

Vancouver

He M, Liu A, Shi J, Xu YJ, Liu Y. Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes. Cannabis & Cannabinoid Research. 2024. doi:10.1089/can.2022.0331

BibTeX
@article{He2024,
  author = {He, Mengxue and Liu, Aiyang and Shi, Jiachen and Xu, Yong-Jiang and Liu, Yuanfa},
  title = {Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes},
  journal = {Cannabis & Cannabinoid Research},
  year = {2024},
  doi = {10.1089/can.2022.0331}
}
Kostenlos starten →